Skip to main content

Table 1 Patient characteristics of the study groups

From: Coagulation competence for predicting perioperative hemorrhage in patients treated with lactated Ringer’s vs. Dextran - a randomized controlled trial

 

Dextran (n = 19)

Lactated Ringer’s (n = 18)

P value

Preoperative variables

 Age – yrs.

68.1 (61.9–74.3)

67.8 (64.1–71.6)

0.94

 Male – sex

15 (79 %)

12 (67 %)

0.48

 Body weight (kg)

77.3 (56–99)

77.2 (52–110)

0.97

 BMI – kg/m2

25.3 (24.1–26.8)

24.8 (23.7–28.3)

0.66

 ASA – class

2.0 (1–3)

2.0 (1–3)

0.48

 Cardiopulmonary disease

11 (58 %)

11 (61 %)

1.00

Intraoperative variables

 Anesthesia (min)

210 (198–275)

210 (211–260)

0.93

 Blood loss >1500 ml

11 (58 %)

4 (22 %)

0.04

 PRBCs

12 (63 %)

5 (28 %)

0.04

 Ephedrine (mg)

16.7 (8.8–24.5)

29.2 (20.2–38.2)

0.03

Postoperative variables

 Straight track a

4 (21 %)

11 (61 %)

0.02

 Days until bowel movement

3.0 (1–7)

2.5 (2–30)

0.60

 Complications

7 (37 %)

3 (17 %)

0.26

 Re-operations

5 (26 %)

2 (11 %)

0.40

 Hospital stay (days)

9.0 (5–24)

7.0 (6–92)

0.69

  1. Values are either numbers (n), percentages (%), means or medians with 95 % confidence interval, or range. P-value by univariate analysis. BMI, body mass index; ASA class, American Society of Anesthesiologists, PRBC, packed red cells, a length of stay, ≤ 7 days without complications requiring treatment